HIV Treatment Adherence Dose Determination Trial
Recruiting · NCT04577313 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Connecticut
View the official record on ClinicalTrials.gov →Interventions studied
Behavioral Self-Regulation Adherence Counseling
What this trial is about
The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Confirmed HIV positive
- Confirmed prescribed antiretroviral therapy
- Confirmed non-adherent to anti-retroviral therapy
Exclusion criteria
- Does not have access to a phone
- Does not have access to the internet
Where it is running
2 locations listed across 2 US states.
- University of Connecticut - Storrs, Connecticut, United States
- University of Connecticut Field Site - Atlanta, Georgia, United States